Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
Patients with type 1 diabetes trained in multiple daily insulin injection were treated with
two diffferent kinds of long acting insulin preparations. The two insulin preparations were
glargine and ultralente insulin. Patients were randomized to receive one of the two insulin
preparations for the first 4 months followed by the second preparation for a further four
months. Short acting insulin used was the same during both periods. We found that glargine
insulin was better than ultralente insulin in our study.